Physician profile
Daniel E Fox
NPI 1538131560
$1,131.86
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $551 · 2021: $221 · 2022: $99.55.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $407.44 | 2019-2022 | |
| Nuvasive, INC. | $378.55 | 2020 | |
| Pacira Therapeutics, INC. | $73.83 | 2019 | |
| Fidia Pharma USA INC. | $48.28 | 2019 | |
| Zimmer Biomet Holdings, INC. | $33.45 | 2022 | |
| Orthogenrx INC. | $29.57 | 2021 | |
| Depuy Synthes Sales INC. | $25.71 | 2019 | |
| Vertical Pharmaceuticals, LLC | $24.52 | 2019 | |
| Bioventus LLC | $22.31 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $15.00 | 2021 | |
| Biogen, INC. | $14.12 | 2022 | |
| Heraeus Medical, LLC. | $13.24 | 2021 | |
| Pacira Cryotech Incorporated | $13.21 | 2019 | |
| Ibsa Pharma INC. | $11.41 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $10.95 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $10.27 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.